Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-like Peptide-1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT01562678
What this trial is testing

Liraglutide in Obesity and Diabetes: Identification of CNS Targets Using fMRI

Who this might be right for
DiabetesEffects of Liraglutide Administration on Brain ActivityWeight Loss+1 more
Beth Israel Deaconess Medical Center 28
Testing effectiveness (Phase 2)Looking for participantsNCT07243171
What this trial is testing

A Phase Ib/IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Ecnoglutide Tablets in Chinese Participants With Overweight or Obesity

Who this might be right for
Overweight and/or ObesityWeight Management
Hangzhou Sciwind Biosciences Co., Ltd. 126
Testing effectiveness (Phase 2)Study completedNCT06901648
What this trial is testing

HS-20094 in Patients With T2DM

Who this might be right for
Type 2 Diabetes
Jiangsu Hansoh Pharmaceutical Co., Ltd. 275
Not applicableStudy completedNCT05468632
What this trial is testing

A Study in North Macedonia Investigating Retrospective Data of Glucagon-like Peptide-1 (GLP-1) Participants With Type 2 Diabetes (T2D) in Real World Environment (RWE) Setting (MIRAGE)

Who this might be right for
Diabetes Mellitus, Type 2
Novo Nordisk A/S 314
Large-scale testing (Phase 3)Study completedNCT02042664
What this trial is testing

Effect of GLP-1 Receptor (GLP-1R) Agonists on Cardiac Function and on Epicardial Adipose Tissue (EAT) Volume and on Myocardial TG Content in Obese Diabetics

Who this might be right for
ObesityDiabetes
Assistance Publique Hopitaux De Marseille 44
Post-approval studies (Phase 4)Study completedNCT04781998
What this trial is testing

Is Saxenda® a Viable Treatment of Obese Patients in Forensic Psychiatry?

Who this might be right for
Mental DisorderMetabolic DisturbanceFeasibility+2 more
Anders Fink-Jensen, MD, DMSci 24
Not applicableStudy completedNCT06818032
What this trial is testing

Avocado and Postprandial Responses

Who this might be right for
HealthyHealthy VolunteerHealthy Volunteers+5 more
University of Vermont Medical Center 30
Testing effectiveness (Phase 2)Study completedNCT03141632
What this trial is testing

Effects of Glucagon Like Peptide 1 (GLP-1) Analogues on Fluid Intake

Who this might be right for
ThirstWater-Electrolyte Imbalance
University Hospital, Basel, Switzerland 17
Testing effectiveness (Phase 2)Study completedNCT00674466
What this trial is testing

Evaluate the Efficacy and Safety of CJC-1134-PC in Patients With Type 2 Diabetes Who Are Currently on Metformin Monotherapy

Who this might be right for
Type 2 Diabetes Mellitus
ConjuChem 90
Not applicableLooking for participantsNCT07517042
What this trial is testing

ASCEND-1: Lifestyle Intervention Plus Mazdutide for Weight Management

Who this might be right for
ObesityWeight Control
Shanghai Zhongshan Hospital 420
Early research (Phase 1)Study completedNCT02673554
What this trial is testing

The Reduced Insulinotropic Effect of a Continuous Infusion Relative to a Bolus Injection of GIP

Who this might be right for
Type 2 Diabetes
Diabeteszentrum Bad Lauterberg im Harz 30
Early research (Phase 1)Ended earlyNCT02550145
What this trial is testing

Role of GLP-1 in Hyperinsulinemic Hypoglycemia Post-bariatric Surgery

Who this might be right for
Hypoglycemia
Tracey McLaughlin 10
Large-scale testing (Phase 3)Not Yet RecruitingNCT07734792
What this trial is testing

Tirzepatide in Thrombectomy-Treated Acute Ischemic Stroke: A Randomized Trial

Who this might be right for
Acute Ischemic Stroke (AIS)
yifang zhu 430
Not applicableLooking for participantsNCT07437911
What this trial is testing

A Randomized, Triple-blind, Placebo-controlled Study to Evaluate the Effects of a Supplement on Nutrient Gaps and Gut Health Among Individuals Utilizing GLP-1 RAs

Who this might be right for
Nutrition IntakeNutrition StatusGastrointestinal Microbiome+1 more
Athletic Greens International 120
Not applicableStudy completedNCT06818292
What this trial is testing

Investigation of the Relationship Between Peripheral and Central Metabolic Changes Induced by GLP-1 Agonists

Who this might be right for
Healthy
Nils Opel 10
Testing effectiveness (Phase 2)Looking for participantsNCT07107334
What this trial is testing

Estimate Early Clinical Efficacy Signals of GLP-1 Agonist Administration in Conjunction With Levonorgestrel Intrauterine Device in Obese Patients With Endometrioid Intraepithelial Neoplasia

Who this might be right for
Endometrioid Endometrial Adenocarcinoma
University of Florida 20
Early research (Phase 1)Ended earlyNCT05762744
What this trial is testing

Pharmacogenomics of GLP1 Receptor Agonists

Who this might be right for
Type 2 Diabetes
University of Maryland, Baltimore 63
Not applicableEnrolling By InvitationNCT01511393
What this trial is testing

An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC)

Who this might be right for
DiabetesDiabetes Mellitus, Type 2Medullary Thyroid Carcinoma+1 more
Novo Nordisk A/S 6,750
Post-approval studies (Phase 4)UnknownNCT02055014
What this trial is testing

Randomisation to Endobarrier Alone Versus With Incretin Analogue in SustainEd Diabesity (REVISE-Diabesity)

Who this might be right for
Type 2 DiabetesObesityDiabesity
Sandwell & West Birmingham Hospitals NHS Trust 72
Post-approval studies (Phase 4)WithdrawnNCT02198209
What this trial is testing

Liraglutide Actions on the Liver: Effects on Glucose Phosphorylation

Who this might be right for
Type 2 Diabetes
Cedars-Sinai Medical Center
Next Page